Advertisement

Tobacco Smoking and Risk for Pulmonary Fibrosis

A Prospective Cohort Study From the UK Biobank

      Background

      Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease of unknown origin. A limited number of small studies show an effect of tobacco smoking on risk of IPF, but second-hand smoking has not been examined.

      Research Question

      Are smoking-related exposures associated with risk of IPF and does interaction between them exist?

      Study Design and Methods

      We designed a prospective cohort study using UK Biobank data, including 437,453 nonrelated men and women of White ethnic background (40-69 years of age at baseline). We assessed the effect of tobacco smoking-related exposures on risk for IPF using Cox regression adjusted for age, sex, Townsend deprivation index, and home area population density. We also examined potential additive and multiplicative interaction between these exposures. Multiple imputation with chained equations was used to address missing data.

      Results

      We identified 802 incident IPF cases. We showed an association between smoking status (hazard ratio [HR], 2.12; 95% CI, 1.81-2.47), and maternal smoking (HR, 1.38; 95% CI, 1.18-1.62) with risk of IPF. In ever smokers, a dose-response relationship was observed between pack-years of smoking and risk of IPF (HR per 1-pack-year increase, 1.013; 95% CI, 1.009-1.016). Furthermore, an additive and multiplicative interaction was observed between maternal smoking and smoking status, with a relative excess risk due to interaction of 1.00 (95% CI, 0.45-1.54) and a ratio of HRs of 1.50 (95% CI, 1.05-2.14).

      Interpretation

      Active and maternal tobacco smoking have an independent detrimental effect on risk of IPF and work synergistically. Also, intensity of smoking presents a dose-response association with IPF, strengthening the hypothesis for a potentially causal association.

      Key Words

      Abbreviations:

      HR (hazard ratio), ICD (International Classification of Diseases), IPF (idiopathic pulmonary fibrosis)
      To read this article in full you will need to make a payment
      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Castelino F.V.
        • Varga J.
        Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management.
        Arthritis Res Ther. 2010; 12: 213
        • Meltzer E.B.
        • Noble P.W.
        Idiopathic pulmonary fibrosis.
        Orphanet J Rare Dis. 2008; 3: 8
        • Martinez F.J.
        • Collard H.R.
        • Pardo A.
        • et al.
        Idiopathic pulmonary fibrosis.
        Nat Rev Dis Prim. 2017; 3: 17074
        • Salvatore M.
        • Ishikawa G.
        • Padilla M.
        Is it idiopathic pulmonary fibrosis or not?.
        J Am Board Fam Med. 2018; 31: 151-162
        • Hutchinson J.
        • Fogarty A.
        • Hubbard R.
        • McKeever T.
        Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.
        Eur Respir J. 2015; 46: 795-806
        • Ley B.
        • Collard H.R.
        • King T.E.
        Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
        Am J Respir Crit Care Med. 2011; 183: 431-440
        • Allen R.J.
        • Porte J.
        • Braybrooke R.
        • et al.
        Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.
        Lancet Respir Med. 2017; 5: 869-880
        • Richeldi L.
        • Collard H.R.
        • Jones M.G.
        Idiopathic pulmonary fibrosis.
        Lancet. 2017; 389: 1941-1952
        • Johannson K.A.
        • Balmes J.R.
        • Collard H.R.
        Air pollution exposure.
        Chest. 2015; 147: 1161-1167
        • Blanc P.D.
        • Annesi-Maesano I.
        • Balmes J.R.
        • et al.
        The occupational burden of nonmalignant respiratory diseases. An Official American Thoracic Society and European Respiratory Society statement.
        Am J Respir Crit Care Med. 2019; 199: 1312-1334
        • Baumgartner K.B.
        • Samet J.M.
        • Stidley C.A.
        • Colby T.V.
        • Waldron J.A.
        Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis.
        Am J Respir Crit Care Med. 1997; 155: 242-248
        • Scott J.
        • Johnston I.
        • Britton J.
        What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust.
        BMJ. 1990; 301: 1015-1017
        • Hubbard R.
        • Lewis S.
        • Richards K.
        • Johnston I.
        • Britton J.
        Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis.
        Lancet. 1996; 347: 284-289
        • Weiss W.
        Cigarette smoking, asbestos, and pulmonary fibrosis.
        Am Rev Respir Dis. 1971; 104: 223-227
        • Iwai K.
        • Mori T.
        • Yamada N.
        • Yamaguchi M.
        • Hosoda Y.
        Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure.
        Am J Respir Crit Care Med. 1994; 150: 670-675
        • Ekström M.
        • Gustafson T.
        • Boman K.
        • et al.
        Effects of smoking, gender and occupational exposure on the risk of severe pulmonary fibrosis: a population-based case-control study.
        BMJ Open. 2014; 4e004018
        • von Elm E.
        • Altman D.G.
        • Egger M.
        • Pocock S.J.
        • Gøtzsche P.C.
        • Vandenbroucke J.P.
        The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
        J Clin Epidemiol. 2008; 61: 344-349
        • Sudlow C.
        • Gallacher J.
        • Allen N.
        • et al.
        UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.
        PLoS Med. 2015; 12e1001779
        • Herbert A.
        • Wijlaars L.
        • Zylbersztejn A.
        • Cromwell D.
        • Hardelid P.
        Data resource profile: Hospital Episode Statistics Admitted Patient Care (HES APC)..
        Int J Epidemiol. 2017; 46 (1093-1093i)
        • Bycroft C.
        • Freeman C.
        • Petkova D.
        • et al.
        The UK Biobank resource with deep phenotyping and genomic data.
        Nature. 2018; 562: 203-209
        • Jones N.
        • Schneider G.
        • Kachroo S.
        • Rotella P.
        • Avetisyan R.
        • Reynolds M.W.
        A systematic review of validated methods for identifying pulmonary fibrosis and interstitial lung disease using administrative and claims data.
        Pharmacoepidemiol Drug Saf. 2012; 21: 256-260
        • Navaratnam V.
        • Fogarty A.W.
        • Glendening R.
        • McKeever T.
        • Hubbard R.B.
        The increasing secondary care burden of idiopathic pulmonary fibrosis.
        Chest. 2013; 143: 1078-1084
        • Raghu G.
        • Weycker D.
        • Edelsberg J.
        • Bradford W.Z.
        • Oster G.
        Incidence and prevalence of idiopathic pulmonary fibrosis.
        Am J Respir Crit Care Med. 2006; 174: 810-816
        • Cottin V.
        • Schmidt A.
        • Catella L.
        • et al.
        Burden of idiopathic pulmonary fibrosis progression: a 5-year longitudinal follow-up study.
        PLoS One. 2017; 12e0166462
        • Raghu G.
        • Collard H.R.
        • Egan J.J.
        • et al.
        An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
        Am J Respir Crit Care Med. 2011; 183: 788-824
        • Wain L.V.
        • Shrine N.
        • Miller S.
        • et al.
        Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank.
        Lancet Respir Med. 2015; 3: 769-781
        • Benjamin D.J.
        • Berger J.O.
        • Johannesson M.
        • et al.
        Redefine statistical significance.
        Nat Hum Behav. 2018; 2: 6-10
        • Bradburn M.J.
        • Clark T.G.
        • Love S.B.
        • Altman D.G.
        Survival analysis part III: multivariate data analysis-choosing a model and assessing its adequacy and fit.
        Br J Cancer. 2003; 89: 605-611
        • Midi H.
        • Sarkar S.K.
        • Rana S.
        Collinearity diagnostics of binary logistic regression model.
        J Interdiscip Math. 2010; 13: 253-267
        • Alin A.
        Multicollinearity.
        Wiley Interdiscip Rev Comput Stat. 2010; 2: 370-374
        • White I.R.
        • Royston P.
        • Wood A.M.
        Multiple imputation using chained equations: issues and guidance for practice.
        Stat Med. 2011; 30: 377-399
        • Graham J.W.
        • Olchowski A.E.
        • Gilreath T.D.
        How many imputations are really needed? Some practical clarifications of multiple imputation theory.
        Prev Sci. 2007; 8: 206-213
        • White I.R.
        • Royston P.
        Imputing missing covariate values for the Cox model.
        Stat Med. 2009; 28: 1982-1998
        • Rubin D.
        Multiple Imputation for Nonresponse in Surveys.
        John Wiley and Sons, 2004
        • VanderWeele T.J.
        • Ding P.
        Sensitivity analysis in observational research: introducing the E-value.
        Ann Intern Med. 2017; 167: 268-274
        • Knol M.J.
        • VanderWeele T.J.
        Recommendations for presenting analyses of effect modification and interaction.
        Int J Epidemiol. 2012; 41: 514-520
        • Assmann S.F.
        • Hosmer D.W.
        • Lemeshow S.
        • Mundt K.A.
        Confidence intervals for measures of interaction.
        Epidemiology. 1996; 7: 286-290
        • Mathur M.B.
        • Ding P.
        • Riddell C.A.
        • VanderWeele T.
        J. Web Site and R Package for Computing E-values.
        Epidemiology. 2018; 29: e45-e47
        • Abramson M.J.
        • Murambadoro T.
        • Alif S.M.
        • et al.
        Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case-control study.
        Thorax. 2020; 75: 864-869
        • Hofhuis W.
        • de Jongste J.C.
        • Merkus P.J.F.M.
        Adverse health effects of prenatal and postnatal tobacco smoke exposure on children.
        Arch Dis Child. 2003; 88: 1086-1090
        • Hackshaw A.
        • Rodeck C.
        • Boniface S.
        Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls.
        Hum Reprod Update. 2011; 17: 589-604
        • Tager I.B.
        • Ngo L.
        • Hanrahan J.P.
        Maternal smoking during pregnancy. Effects on lung function during the first 18 months of life.
        Am J Respir Crit Care Med. 1995; 152: 977-983
        • Hollams E.M.
        • de Klerk N.H.
        • Holt P.G.
        • Sly P.D.
        Persistent effects of maternal smoking during pregnancy on lung function and asthma in adolescents.
        Am J Respir Crit Care Med. 2014; 189: 401-407
        • Cunningham J.
        • Dockery D.W.
        • Speizer F.E.
        Maternal smoking during pregnancy as a predictor of lung function in children.
        Am J Epidemiol. 1994; 139: 1139-1152
        • Hayatbakhsh M.R.
        • Sadasivam S.
        • Mamun A.A.
        • Najman J.M.
        • Williams G.M.
        • O'Callaghan M.J.
        Maternal smoking during and after pregnancy and lung function in early adulthood: a prospective study.
        Thorax. 2009; 64: 810-814
        • Perret J.L.
        • Walters H.
        • Johns D.
        • et al.
        Mother’s smoking and complex lung function of offspring in middle age: a cohort study from childhood.
        Respirology. 2016; 21: 911-919
        • Magnus M.C.
        • Henderson J.
        • Tilling K.
        • Howe L.D.
        • Fraser A.
        Independent and combined associations of maternal and own smoking with adult lung function and COPD.
        Int J Epidemiol. 2018; 47: 1855-1864
        • Weiss W.
        Smoking and pulmonary fibrosis.
        J Occup Med. 1988; 30: 33-39
        • Foronjy R.
        • D’Armiento J.
        The effect of cigarette smoke-derived oxidants on the inflammatory response of the lung.
        Clin Appl Immunol Rev. 2006; 6: 53-72
        • National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health
        The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General.
        Centers for Disease Control and Prevention, 2014
        • Sopori M.
        Effects of cigarette smoke on the immune system.
        Nat Rev Immunol. 2002; 2: 372-377
        • Office on Smoking and Health (US)
        The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General.
        Centers for Disease Control and Prevention, 2006
        • Bellou V.
        • Belbasis L.
        • Konstantinidis A.K.
        • Evangelou E.
        Elucidating the risk factors for chronic obstructive pulmonary disease: an umbrella review of meta-analyses.
        Int J Tuberc Lung Dis. 2019; 23: 58-66
        • Einarson A.
        • Riordan S.
        Smoking in pregnancy and lactation: a review of risks and cessation strategies.
        Eur J Clin Pharmacol. 2009; 65: 325-330
        • Fleisch A.F.
        • Rifas-Shiman S.L.
        • Rokoff L.B.
        • Hivert M.-F.
        • Mantzoros C.S.
        • Oken E.
        Associations of maternal prenatal smoking with umbilical cord blood hormones: the Project Viva cohort.
        Metabolism. 2017; 72: 18-26
        • VanderWeele T.J.
        • Mathur M.B.
        Commentary: developing best-practice guidelines for the reporting of E-values.
        Int J Epidemiol. 2020; 49: 1495-1497
        • Trinquart L.
        • Erlinger A.L.
        • Petersen J.M.
        • Fox M.
        • Galea S.
        Applying the E value to assess the robustness of epidemiologic fields of inquiry to unmeasured confounding.
        Am J Epidemiol. 2019; 188: 1174-1180
        • Hamra G.B.
        RE: ‘Applying the E value to assess the robustness of epidemiologic fields of inquiry to unmeasured confounding’.
        Am J Epidemiol. 2019; 188: 1578-1580
        • VanderWeele T.J.
        • Ding P.
        • Mathur M.
        Technical considerations in the use of the E-value.
        J Causal Inference. 2019; 7: 1-11
        • Fry A.
        • Littlejohns T.J.
        • Sudlow C.
        • et al.
        Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population.
        Am J Epidemiol. 2017; 186: 1026-1034
        • Coughlin S.S.
        Recall bias in epidemiologic studies.
        J Clin Epidemiol. 1990; 43: 87-91
        • Simard J.F.
        • Rosner B.A.
        • Michels K.B.
        Exposure to cigarette smoke in utero: comparison of reports from mother and daughter.
        Epidemiology. 2008; 19: 628-633
        • Connor Gorber S.
        • Schofield-Hurwitz S.
        • Hardt J.
        • Levasseur G.
        • Tremblay M.
        The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status.
        Nicotine Tob Res. 2009; 11: 12-24